ERBA Diagnostics, Inc., through its subsidiaries, develops, manufactures, and markets diagnostic test kits or assays, and automated systems that are used to aid in the detection of disease markers primarily in the areas of autoimmune, infectious diseases, clinical chemistry, hematology, and diabetes testing. It manufactures scientific and laboratory instruments, such as Mago 4, Mago 4S, and Mago Plus systems, which perform tests in an automated mode; sells other diagnostic products manufactured by third parties in Italy; and develops, manufactures, and markets raw materials, such as antigens that are used in the production of diagnostic kits. The company also develops, manufactures, and markets autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers. In addition, the company provides instruments for blood cell counting and blood analysis; supplies reagents and other consumable materials; sells diabetic testing products, including the DS5 instrument, dispenser, and associated reagent kits, which measure long-term glucose control in diabetic patients; and offers equipment for use in the field of human and veterinary hematology. Further, it manufactures and sells liquid stable, diagnostics chemistry reagents used for in vitro diagnostics testing. The company markets its products through its sales force to hospitals, reference laboratories, clinical laboratories, and research laboratories, as well as to other commercial companies that manufacture diagnostic products in the United States; and through sales representatives and independent agents in Italy, as well as through independent distributors internationally. The company was founded in 1980 and is headquartered in Miami Lakes, Florida. ERBA Diagnostics, Inc. is a subsidiary of ERBA Diagnostics Mannheim GmbH.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ERBA
Previous SymbolNYSEMKT:ERB
CUSIPN/A
Phone305-324-2300
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares48,750,000
Market Cap$13.70 million
OptionableNot Optionable
ERBA Diagnostics (OTCMKTS:ERBA) Frequently Asked Questions
What is ERBA Diagnostics' stock symbol?
ERBA Diagnostics trades on the OTCMKTS under the ticker symbol "ERBA."
Has ERBA Diagnostics been receiving favorable news coverage?
Headlines about ERBA stock have been trending very positive on Monday, InfoTrie reports. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ERBA Diagnostics earned a news sentiment score of 3.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the near term.
Who are some of ERBA Diagnostics' key competitors?
Some companies that are related to ERBA Diagnostics include Vistagen Therapeutics (VTGN), Aquinox Pharmaceuticals (AQXP), Avenue Therapeutics (ATXI), Acasti Pharma (ACST), Forward Pharma A/S (FWP), Conatus Pharmaceuticals (CNAT), Trevena (TRVN), Aptevo Therapeutics (APVO), Nemus Bioscience (NMUS), OncoSec Medical (ONCS), Leap Therapeutics (LPTX), Evoke Pharma (EVOK), GT Biopharma (GTBP), Zosano Pharma (ZSAN) and DiaMedica Therapeutics (DMCAF).
Who are ERBA Diagnostics' key executives?
ERBA Diagnostics' management team includes the folowing people:
- Mr. Suresh Vazirani, Exec. Chairman & MD (Age 68)
- Mr. David Barka, Interim Chief Exec. Officer (Age 37)
- Dr. Chandra Krishnan, Sr. VP of Global Sales, Marketing and Bus. Devel.
- Mr. Ray Earl, VP of Sales - Diamedix Corp
How do I buy shares of ERBA Diagnostics?
Shares of ERBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is ERBA Diagnostics' stock price today?
One share of ERBA stock can currently be purchased for approximately $0.2810.
How big of a company is ERBA Diagnostics?
ERBA Diagnostics has a market capitalization of $13.70 million.
What is ERBA Diagnostics' official website?
How can I contact ERBA Diagnostics?
ERBA Diagnostics' mailing address is 14100 Nw 57th Court, Miami Lakes FL, 33014. The company can be reached via phone at 305-324-2300 or via email at [email protected]
MarketBeat Community Rating for ERBA Diagnostics (OTCMKTS ERBA)
MarketBeat's community ratings are surveys of what our community members think about ERBA Diagnostics and other stocks. Vote "Outperform" if you believe ERBA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ERBA will underperform the S&P 500 over the long term. You may vote once every thirty days.
